Gyre Therapeutics, Inc. GYRE Gyre — Other Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — other nonoperating income expense of $191K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense increased by 324.4% year-over-year, from $45K to $191K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre — other nonoperating income expense has grown at a -65.2% compound annual growth rate (CAGR), from -$272K to -$33K.
- What does gyre — other nonoperating income expense mean?
- This captures financial impacts that fall outside the scope of the segment's primary business operations, such as foreign exchange gains or losses, asset disposals, or miscellaneous income. It provides a view of peripheral financial activities that affect the overall bottom line. Investors analyze this to isolate core operational performance from incidental financial events.